Clinical implications of COVID-19 in patients with chronic liver disease and liver tumor
- PMID: 32504266
- PMCID: PMC7273121
- DOI: 10.1007/s13304-020-00804-8
Clinical implications of COVID-19 in patients with chronic liver disease and liver tumor
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- Chai Longfei Hu, Zhang Y, Han W, Zhou Lu, Ke A, Zhou J, Shi G, Fang N, Fan J, Cai J, Fan J, Lan F. Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection. BioRxiv. 2020 doi: 10.1101/2020.02.03.931766. - DOI
-
- Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, Liu S, Zhao P, Liu H, Zhu L, Tai Y, Bai C, Gao T, Song J, Xia P, Dong J, Zhao J, Wang FS. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8(4):420–422. doi: 10.1016/S2213-2600(20)30076-X. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical